⌘K

Home/Filings/4/0001104659-23-069503

4//SEC Filing

Kelly Steven 4

Accession 0001104659-23-069503

CIK 0001485003other

View on SEC.gov Company Profile

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 6:20 PM ET

Size

5.8 KB

Accession

0001104659-23-069503

Insider Transaction Report

Form 4

Period: 2023-06-06

Carisma Therapeutics Inc.CARM

DirectorPresident and CEO

Transactions

Award
Stock Option (Right to Buy)
2023-06-06+600,000→ 600,000 total
Exercise: $7.25Exp: 2033-06-06→ Common Stock (600,000 underlying)

Footnotes (1)

[F1]The shares underlying this option vest over four years, with 25% of the shares vesting on June 6, 2024 and the remaining shares vesting over the next three years thereafter in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.

Documents

1 file

4
tm2318219-7_4seq.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Carisma Therapeutics Inc.

CIK 0001485003

Entity typeother

Related Parties

1

filerCIK 0001339478

Filing Metadata

Form type: 4
Filed: Jun 7, 8:00 PM ET
Accepted: Jun 8, 6:20 PM ET
Size: 5.8 KB

View on SEC.gov